Stem Cell Therapy Shows Promise in Treating Advanced Parkinson’s Disease
A stem cell-based therapy developed at Memorial Sloan Kettering Cancer Center (MSK) has shown promising results in treating advanced Parkinson’s disease, according to a phase 1 clinical trial published in Nature. The treatment involves creating nerve cells derived from embryonic stem cells and transplanting them into the brains of patients with Parkinson’s. The injected cells … Read more